The study found that BCAAs are associated with obesity-related metabolic disorders, BCAAs aggravate obesity-related hepatic glucolipid metabolism disorders by weakening AKT2 signaling pathway and supplementing BCAAs significantly increased hepatic gluconeogenesis in high-fat diet-induced obese mice and inhibited hepatic lipogenesis. This evidence concerns the gene AKT2 and Other metabolic disease.